Background: The aim of this study was to investigate the validity and reliability of the HeartQoL instrument in a population of stable coronary patients. Design: Analyses are based on the cross-sectional EUROASPIRE IV (EUROpean Action on Secondary and Primary prevention through Intervention to Reduce Events) survey. Methods: Patients with a diagnosis of coronary heart disease were examined and interviewed 6 months to 3 years after their coronary event. During the interview patients were asked to fill out the HeartQoL health-related quality of life questionnaire as well as the EQ-5D and the hospital anxiety and depression scale questionnaire. Psychometric analyses assessing the reliability and validity of the HeartQoL instrument were performed. Results: A total of 7449 patients completed the HeartQoL instrument. Cronbach's alpha indicated excellent internal consistency for the global HeartQoL scale ( ¼ 0.92) and the physical subscale ( ¼ 0.91) and good internal consistency for the emotional subscale ( ¼ 0.87). Factor analysis confirmed the two-dimensional construct although mixed results were found regarding the model fit. Discriminative validity analysis confirmed better HeartQoL results in men, younger patients and higher educated persons. Likewise, convergent validity was confirmed with moderate to strong correlations among hypothesised constructs. Conclusion: Overall, psychometric analyses of the HeartQoL instrument in a population of patients with stable coronary heart disease showed good reliability and validity both at the European as well as the country-specific level. However, further research should focus on the responsiveness of the HeartQoL, the possible ceiling effect of the emotional subscale, construct validity and the minimal clinically important difference.
Introduction
Life expectancy has increased substantially in Europe from 65.6 years in the late 1950s to 76.5 years currently. 1 While the drop in coronary heart disease (CHD) mortality is partly responsible for this evolution, population ageing is also associated with an increase in CHD morbidity, accounting for 10% of total disability adjusted life years. 2 In addition to the focus on clinical measures and functional outcomes, an increased awareness of the importance of patientreported outcomes such as health-related quality of life (HRQL) has emerged. 3 Within this context, several tools have been developed to assess patients' physical, emotional and social wellbeing. Many generic instruments such as the EQ-5D and the short form 36 (SF-36) exist, allowing comparison across different patient groups. [4] [5] [6] Furthermore, a number of CHD-specific instruments are available, useful in specific patient groups and often more sensitive in capturing small differences between patients; for example, the Seattle angina questionnaire for patients with angina 7 and the MacNew heart disease quality of life questionnaire originally designed for patients with myocardial infarction (MI) but also valid in patients with angina and heart failure. 8 As comparison between the different patients groups is difficult with the existing disease-specific tools, the HeartQoL questionnaire was designed to be a single reliable and valid core HRQL instrument in patients with CHD for making between-diagnosis comparisons possible and to assess the change in HRQL after treatment. 9, 10 The HeartQoL consists of 14 items; 10 items focus on physical wellbeing and four items on emotional wellbeing, together providing a global scale.
The psychometric properties of the HeartQoL have been assessed in the original HeartQoL project sample of 6384 patients from 22 countries being actively treated for one of the three major CHD diagnoses, that is, angina, MI and ischaemic heart failure. 9 The aim of the current study was to determine and confirm or extend (as some languages were not available in the original study) the reliability and validity of the HeartQoL in an independent large European sample of 7449 patients with CHD from 24 different European countries, who were in a stable phase of their disease using the EUROASPIRE IV (EUROpean Action on Secondary and Primary Prevention through Intervention to Reduce Events) survey data. 11 
Methods

Study population and data collection
Analyses were based on data gathered during the recent EUROASPIRE IV survey, performed in 2012-2013 in 24 European countries: Belgium, Bosnia Herzegovina, Bulgaria, Croatia, Cyprus, Czech Republic, Finland, France, Germany, Greece, Ireland, Latvia, Lithuania, The Netherlands, Poland, Romania, Russian Federation, Serbia, Slovenia, Spain, Sweden, Turkey, Ukraine and the UK. 11 Patients eligible for inclusion were men or women, aged !18 years and <80 years, who had been hospitalised for a first or recurrent coronary event, defined as the recruiting event, including elective or emergency coronary artery bypass graft surgery, elective or emergency percutaneous coronary intervention, first or recurrent acute ST elevation and non-ST elevation MI or acute myocardial ischaemia. Patients were interviewed 6 months to 3 years following the recruiting event.
Patient-reported outcomes were assessed using three questionnaires: the HeartQoL, 10 the EuroQol group's five-level version of the EQ-5D: the EQ-5D-5L 12 and the hospital anxiety and depression scale (HADS). 13 In each country, questionnaires were administered in the official language.
The HeartQoL comprises 14 items with four response categories each ranging from 'not bothered' to 'bothered a lot'. In the original HeartQoL development paper by Oldridge et al., a bi-dimensional instrument was proposed with a 10-item physical subscale and a four-item emotional subscale (see items in Table 1 ). 10 Both the global scale (all items), and the physical (10 items) and emotional (four items) subscale scores, ranging between 0 (poor HRQL) and 3 (better HRQL), can be calculated as the mean of the scored items. Validated language versions of the HeartQoL questionnaire were not yet available for some countries included in the EUROASPIRE study (Bulgaria, Bosnia Herzegovina, Czech Republic, Croatia, Cyprus, Finland, Greece, Latvia, Lithuania, Romania, Serbia, Slovenia, Turkey), and a forward and backward translation methodology was used in their translation. 14 The EQ-5D-5L is a widely used simple, generic preference-based instrument to measure health status in a standardised way. 4, 15, 16 The measure is applicable to a wide range of conditions and treatments and contains a self-classifier made up of five Likert-scale items on mobility, self-care, usual activities, pain/discomfort and anxiety/depression from which a single summary index can be derived, 17 and a visual analogue scale (EQ-VAS) asking the patient to indicate on a 20 cm vertical scale how good or bad his/her health status is today, anchored by best imaginable health and worst imaginable health. Within this study, the index scores were based on the so-called crosswalk value set for the UK. The crosswalk value set is an interim value set for EQ-5D-5L (based on the EQ-5D-3L value sets) in the absence of valuation studies that directly elicit preferences from general population samples. 18 Index values can range between À0.594 and 1, with 1 representing full health, 0 representing death, and <0 representing a health state perceived worse than death.
The HADS instrument, containing 14 items with four response categories each, permits calculation of both an anxiety score (HADS-A) and a depression score (HADS-D). The total score on each subscale ranges between 0 and 21. A score <8 can be considered as being in the normal range, higher scores indicate a possible or probable disorder. 13, 19 Psychometric analyses Reliability and validity of the HeartQoL instrument were assessed in the current study. 20 Stratification by country, gender, age group (<60 years, 60-69 years and !70 years) and educational level (primary school or less; secondary school completed, high school completed or intermediate between secondary level completed; university/college degree or equivalent) was performed. A conservative approach was applied, excluding patient records from the analyses for which at least one HeartQoL item was missing. All analyses were performed using IBM SPSS 22, except the exploratory factory analyses (EFA) and confirmatory factor analyses (CFA), which were conducted using Mplus version 7.2.
Reliability. Cronbach's alpha was used to assess the internal consistency of the instruments. A threshold of 0.7 was considered acceptable, a value >0.8 was considered as good, and a value >0.9 as excellent. 21 Validity. EFA was performed on our sample in order to explore the underlying factor structure. In addition, CFA was used to test whether the original scale construct, proposed by Oldridge et al., could be confirmed in our sample. 10 The weighted least squares means and variance adjusted estimation method was applied with ordinal data. Multiple goodness of fit tests were used to assess the model fit, including the root mean square error of approximation (RMSEA), the comparative fit index (CFI) and the Tucker-Lewis index (TLI). The CFI and TLI range between 0 and 1 with a value >0.9 being considered as an acceptable model fit. 22 RMSEA values also range between 0 and 1, with a value <0.06 being considered as a good fit, a value <0.08 was considered as an acceptable fit and a value >0.1 led to rejection of the model. 23, 24 Factor loadings represent the correlation between items and factor. Standardised factor loadings >0.5 were perceived as good, loadings >0.4 indicated an acceptable correlation and those <0.4 were perceived as not good.
Discriminative validity was examined with the known groups method based on multilevel linear models to account for the clustering of patients within countries. 25 Based on literature findings we hypothesised that HRQL would decrease with age and lower education, and would be lower in women and anxious or depressive patients. [26] [27] [28] [29] [30] Convergent validity was evaluated to assess the correlations between theoretically correlated constructs using Spearman correlation coefficients due to the nonnormal distribution of the constructs. Correlations <0.3 were considered as negligible, a value between 0.3 and 0.5 as moderate and >0.5 as strong. 31 We hypothesised that the global HeartQoL scale and both the HeartQoL physical and the HeartQoL emotional subscales would correlate strongly with the EQ-5D index . Furthermore, the HeartQoL emotional was expected to correlate well with HADS. In line with the paper by Oldridge et al. on the reliability and validity of the tool in the original sample, we assessed the ceiling and floor effect of the tool in comparison with the EQ-5D and the HADS tools. 9 
Results
Patient characteristics
From the 16,426 medical records from patients eligible for inclusion, 7998 patients (48.7%) were interviewed and examined. The HeartQoL instrument was completed by 7449 patients (93.1%) whose mean age was 64 years (ranging from 58.5 to 67.3 years between countries). The majority of patients (76.1%) were men (ranging from 61.6% to 90.5% between countries). The distribution of the recruiting event was as follows: 13.3% coronary artery bypass graft surgery, 55.9% percutaneous coronary intervention, 21.1% acute MI, 9.7% ischaemia. Education levels were as follows: primary education 16.6%; secondary education 60.6%; higher education 22.8%.
Health-related quality of life
The overall and country-specific mean values on the different HRQL constructs are shown in Table 2 . The mean HeartQoL (AESD) scores were as follows: global scale 2.18 AE 0.66; physical subscale 2.13 AE 0.72 and emotional subscale 2.30 AE 0.72. The HeartQoL ceiling effects ranged from 8.1% (global scale) to 28.7% (emotional subscale); the floor effects were always less than 1.2% ( Table 2 ).
Reliability
Overall, reliability was good to excellent on the global scale and both the physical and emotional subscales. Some variation was seen between countries, but for all countries, a good to excellent internal consistency was observed on the global scale (0.85-0.95) and the physical subscale (0.83-0.95) except for Bosnia Herzegovina (0.65 and 0.44, respectively) ( Table 3) . For the HeartQoL emotional subscale, the overall Cronbach's alpha was 0.87, ranging between 0.80 and 0.93 except for Cyprus (0.79), Bosnia Herzegovina (0.77) and Poland (0.67).
Validity
Conceptual model. On the other hand, mixed results were found regarding the construct validity of the tool. Using the data from all patients, the two-factor structure was proposed with EFA. For one item (Q8), EFA factor loadings were similar on both constructs. With CFA, both the TLI (0.94) and the CFI (0.95) showed good fit with the originally proposed constructs, whereas the RMSEA (0.117) suggested rejecting the model. Excellent standardised factor loadings >0.70 were found with the CFA, representing a very good correlation between observed variables and extracted components. We explored the data further in an attempt to resolve the contradictory results among the fit indices. Replacing Q8 from the physical component to the emotional component did not alter the findings and the results were not improved by loading Q8 on both factors. Similarly, performing the CFA only in those countries that participated in the original validation study (Belgium, France, Germany, Hungary, Ireland, Italy, The Netherlands, Poland, Russia, Spain, Sweden, Ukraine, UK) did not alter the results. Finally, performing the CFA analyses on a country-specific level gave similar results for all countries with the exception of Bosnia for which a worse CFA outcome was seen.
Discriminative validity. There were gender, age and educational level differences in the global, physical and emotional scores (all P < 0.001) ( Table 4 ). Women, anxious and depressed patients and primary educated patients reported poorer global, physical and emotional HeartQoL scores. Older patients reported poorer global and physical HeartQoL scores whereas younger patients reported poorer HRQL on the emotional subscale.
Convergent validity. Convergent validity was demonstrated with the HeartQoL global scale, and both the physical and the emotional subscales correlating strongly with the EQ-5D index and moderately with the EQ-VAS. Furthermore, the global HeartQoL and emotional subscale correlated strongly with both HADS scales ( Table 5 ).
Reported problems
In patients with full health on the EQ-5D (no problems on all items), 25.3% scored 'not bothered at all' according to the global HeartQoL score (mean 2.70 AE 0.38), 32.0% were not bothered by any physical subscale item (mean 2.67 AE 0.44) and 58.6% were not bothered by any emotional subscale item (mean 2.76 AE 0.42). Of all the patients indicating best imaginable health status on the EQ-VAS, 31.5% were not bothered at all according to the global scale (mean 2.62 AE 0.54), 37.4% were not bothered on the physical subscale (mean 2.60 AE 0.57) and 62.6% were not bothered according to the emotional subscale (mean 2.66 AE 0.60). 
Discussion
We evaluated the reliability and validity of the HeartQoL questionnaire based on data observed in the EUROASPIRE IV survey on a European sample of 7449 stable coronary patients. Overall, the HeartQoL instrument was shown to be a reliable tool for measuring HRQL in patients with stable CHD, with excellent internal consistency on the global HeartQoL scale and physical subscale and good internal consistency on the emotional subscale. Although EFA proposed the twofactor structure, mixed results were found with CFA regarding the construct validity of the tool. Convergent and discriminative validity were fully confirmed. The internal consistency results in the present study were similar to the initial reliability observations by Oldridge et al., who reported Cronbach's alpha for the global, physical and emotional HeartQoL of 0.91, 0.90 and 0.81, respectively. 9 Performing the reliability analyses on a country-specific level gave similar results for all countries with the exception of Bosnia Herzegovina.
Although the two-factor structure was supported on a theoretical base as well as by the EFA, mixed results were found regarding the construct validity of the tool both on a European as well as on a country-specific level. For Bosnia Herzegovina a worse CFA outcome was seen.
The different distribution of Bosnia compared to the other countries, with fewer patients reporting full health, might explain these aberrant outcomes. Also 128 of the 316 Bosnian patients (40.5%) did not complete the HeartQoL instrument and non-completers had a better cardiovascular risk factor profile. Furthermore, interpretation errors resulting from the translation from English into Bosnian may have occurred.
The discriminative validity of the global HeartQoL scale and both subscales was confirmed with better HeartQoL scores seen in male patients, younger patients, patients with a higher educational level and patients without HADS-A or HADS-D symptoms. These results are supported by literature findings reporting on other HRQL tools. [26] [27] [28] [29] [30] Convergent validity was supported with moderate to strong correlations between theoretically correlated constructs.
The ceiling (best possible score) and floor (worst possible score) effect seen in the EUROASPIRE patient population was similar to the original HeartQoL study. 9 Floor and ceiling effects of 1-15% are considered small. 32 The absence of floor effects indicates that the tool is sensitive for assessing adverse disease progression. In this respect, the HeartQoL tool performs better than the HADS instrument and similar to the EQ-5D instrument. Furthermore, the ceiling effect of the global and physical HeartQoL scales also showed good results. Not unexpected -as it is based on only four items -a substantial ceiling effect on the emotional subscale was seen. It is important to note that the emotional HeartQoL and the HADS are aiming at different constructs. Whereas the HADS items have labels referring to how often problems occur, the HeartQoL asks whether a person is bothered by these problems, therefore the definition of full health differs somewhat between the different tools.
Limitations
Test-retest and responsiveness could not be tested due to the cross-sectional design of the survey. Interpretation of scores needs to be investigated further. A small number of patients, 7% of the total patient group, did not provide HeartQoL information; as this subgroup had a slightly worse risk profile (more men, more ischaemia, lower education, worse EQ-5D and HADS), this could potentially have resulted in a small bias. Furthermore, for some countries (Bulgaria, Bosnia Herzegovia, Czech Republic, Croatia, Cyprus, Finland, Greece, Latvia, Lithuania, Romania, Serbia, Slovenia, Turkey) a validated version of the HeartQoL was not yet available, and even though a standardised forward-backward translation approach was used, some translation bias might have occurred. In addition, the country representativeness of the participating centres could be discussed.
In summary, the HeartQoL questionnaire showed adequate reliability and validity for measuring HRQL in patients with stable CHD in most languages/countries. Specifically targeting cardiovascular patients, it can be a valuable tool to assess their HRQL. It could be a useful tool to assess the effect of treatments on patients' HRQL and hence have an influence on decision making.
Further research should focus on the ceiling effect of the emotional component and its sensitivity to capture small changes, as well as on construct validity and the minimal clinically important difference. Adjustments to the Bosnian translation in order to match better with original questioning might result in better psychometric properties of the Bosnian HeartQoL.
